학술논문

Seroprevalence of SARS-CoV-2 Among Frontline Health Care Personnel in a Multistate Hospital Network — 13 Academic Medical Centers, April–June 2020
Document Type
article
Author
Self, Wesley HTenforde, Mark WStubblefield, William BFeldstein, Leora RSteingrub, Jay SShapiro, Nathan IGinde, Adit APrekker, Matthew EBrown, Samuel MPeltan, Ithan DGong, Michelle NAboodi, Michael SKhan, AkramExline, Matthew CFiles, D ClarkGibbs, Kevin WLindsell, Christopher JRice, Todd WJones, Ian DHalasa, NatashaTalbot, H KeippGrijalva, Carlos GCasey, Jonathan DHager, David NQadir, NidaHenning, Daniel JCoughlin, Melissa MSchiffer, JaradSemenova, VeraLi, HanThornburg, Natalie JPatel, Manish MBaughman, AdrienneHart, Kimberly WMcClellan, RobertMcHenry, RendieJohnson, JakeaFletcher, AndreaRich, CurtisCordero, KemberlyneKozikowski, LoriDe Souza, LesleyRomain, SarahOuellette, ScottSantana, AndresThornton-Thompson, SherellHowell, MichellePeers, JenniferShelton, ShelbyFinck, LaniSoules, KirstenKlausner, MichaelCalderon-Morales, XimenaErickson, Heidi LHendrickson, AudreyStang, JamieMaruggi, EllenDunn, AlexStenehjem, EddieHealthcare, IntermountainAston, ValerieBown, MikaeleMatheu, MichelleSmith, RileeKrol, OliviaSalar, AndrewHealth, OregonKamel, MakrinaNguyen, KellyHuynh, PeterKarow, SarahBright, MichelleBookless, HollyMullins, SandyNeidert, KellyMcGowan, DinaCassandra, ElizabethBrown, EmilyCarlin, ClaireWemlinger, TrinaEdwards, BreonaFlores, LoriLaRose, MaryFerbas, Kathie JMartin-Blais, RachelAldrovandi, Grace MThompson, OliviaSehgal, SakshiAta Ur Rasheed, MohammedMills, LisaLester, Sandra NFreeman, BrandiAlston, BaileyAtegbole, MuyiwaBrowning, PeterCronin, LiDavid, EbenezerDesai, RitaEpperson, Monica
Source
MMWR Morbidity and Mortality Weekly Report. 69(35)
Subject
Health Services and Systems
Biomedical and Clinical Sciences
Clinical Sciences
Health Sciences
Emerging Infectious Diseases
Biodefense
Prevention
Vaccine Related
Infectious Diseases
Lung
Infection
Good Health and Well Being
Academic Medical Centers
Adult
Antibodies
Viral
Asymptomatic Diseases
Betacoronavirus
COVID-19
Coronavirus Infections
Cross Infection
Female
Humans
Infectious Disease Transmission
Professional-to-Patient
Male
Middle Aged
Pandemics
Personal Protective Equipment
Personnel
Hospital
Pneumonia
Viral
SARS-CoV-2
Seroepidemiologic Studies
United States
CDC COVID-19 Response Team
IVY Network
General & Internal Medicine
Language
Abstract
Health care personnel (HCP) caring for patients with coronavirus disease 2019 (COVID-19) might be at high risk for contracting SARS-CoV-2, the virus that causes COVID-19. Understanding the prevalence of and factors associated with SARS-CoV-2 infection among frontline HCP who care for COVID-19 patients are important for protecting both HCP and their patients. During April 3-June 19, 2020, serum specimens were collected from a convenience sample of frontline HCP who worked with COVID-19 patients at 13 geographically diverse academic medical centers in the United States, and specimens were tested for antibodies to SARS-CoV-2. Participants were asked about potential symptoms of COVID-19 experienced since February 1, 2020, previous testing for acute SARS-CoV-2 infection, and their use of personal protective equipment (PPE) in the past week. Among 3,248 participants, 194 (6.0%) had positive test results for SARS-CoV-2 antibodies. Seroprevalence by hospital ranged from 0.8% to 31.2% (median = 3.6%). Among the 194 seropositive participants, 56 (29%) reported no symptoms since February 1, 2020, 86 (44%) did not believe that they previously had COVID-19, and 133 (69%) did not report a previous COVID-19 diagnosis. Seroprevalence was lower among personnel who reported always wearing a face covering (defined in this study as a surgical mask, N95 respirator, or powered air purifying respirator [PAPR]) while caring for patients (5.6%), compared with that among those who did not (9.0%) (p = 0.012). Consistent with persons in the general population with SARS-CoV-2 infection, many frontline HCP with SARS-CoV-2 infection might be asymptomatic or minimally symptomatic during infection, and infection might be unrecognized. Enhanced screening, including frequent testing of frontline HCP, and universal use of face coverings in hospitals are two strategies that could reduce SARS-CoV-2 transmission.